| Title: |
Barriers in Healthcare to the Use of Optical Coherence Tomography Angiography in Multiple Sclerosis. |
| Authors: |
Reeß, Lukas G.1,2,3 (AUTHOR), Salih, Hadi1,3 (AUTHOR), Delikaya, Murat1,3 (AUTHOR), Paul, Friedemann1,3,4 (AUTHOR), Oertel, Frederike Cosima1,3,4 (AUTHOR) frederike-cosima.oertel@charite.de |
| Source: |
Neurology & Therapy. Feb2025, Vol. 14 Issue 1, p45-56. 12p. |
| Subject Terms: |
*MYELIN oligodendrocyte glycoprotein antibody-associated disease, *NEUROMYELITIS optica, *OPTICAL coherence tomography, *MEDICAL sciences, *NEUROLOGICAL disorders |
| Abstract: |
Optical coherence tomography angiography (OCT-A) is a state-of-the-art imaging technique for the retinal vasculature to accurately segment the capillary network and assign it to retinal layers. OCT-A is a promising technique to better understand neurological diseases with visual system manifestations, such as multiple sclerosis (MS), and to identify and characterize vascular biomarkers. Initial studies suggested vascular changes in MS and its differential diagnoses such as myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) and neuromyelitis optica spectrum disorder (NMOSD). Here we review clinical and technical aspects of OCT-A imaging and discuss the potential for the MS field as well as barriers that need to be overcome before OCT-A can be established in clinical application. [ABSTRACT FROM AUTHOR] |
|
Copyright of Neurology & Therapy is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Academic Search Complete |
